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Table 1. Comparison of cross-validated ROC AUCs for both 
endpoints. 
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Purpose/Objective: In this prospective study we investigated 
which anatomical structures that are related to trismus after 
radiation therapy in head and neck cancer (HNC). 
Materials and Methods: 216 consecutively included patients 
with HNC were prospectively followed regarding trismus both 
with respect to mouth opening measured in millimeters (MIO-
Maximal Interincisal Opening) and with validated patient-
reported outcome instruments (European Organization for 
Research and Treatment of Cancer Head and Neck 
Questionnaire (EORTC QLQ-HN35) and Gothenburg Trismus 
Questionnaire (GTQ)). Trismus was defined as any event 
during the first year of follow-up. Patients were assessed 
before radiotherapy and at 3, 6, and 12 months after 
completed oncological treatment. Mean absorbed doses of 
seven potential risk structures (masseter muscle, lateral and 
medial pterygoid muscle, temporal muscle, 
temporomandibular joint, soft palate, and, pterygopalatine 
ganglion (ipsi-, contra-, and bilateral)) were used in logistic 
regression analyses to create predictive models for radiation-
induced trismus.  
 
Results: For all three endpoints (MIO, GTQ, and, EORTC QLQ-
HN35,) we found that mean doses to the masseter muscle and 
the temporomandibular joint were statistically significant 
predictors for trismus. Results for ipsi-, and bilateral 
structures were comparable and the predictive ability given 
by the contralateral risk structures was lower in general. 
Smoking and height were significant risk factors for trismus 
according to MIO, and comorbidity (ACE-27) for trismus 
according to GTQ. Dose to the ipsilateral masseter as 
predictor for trismus according to GTQ, adjusted for ACE-27, 
provided the model with the overall strongest predictive 
ability (Az =0.78).  
Conclusions: Among seven risk structures, masseter muscle 
dose gives the strongest prediction of trismus. The masseter 
muscle may therefore be a possible candidate for future 
organ-sparing techniques to avoid trismus in cases where the 
masseter muscle dose can be safely lowered without 
jeopardizing tumor control. 
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Purpose/Objective: By collecting information from 
electronic health records of large numbers of patients, we 
have entered the era of rapid learning health care (RLHC). 
RLHC systems provide us with an ever-growing amount of 
data and pose the challenge to analyze these data in a 
meaningful way. One area to which RLHC is being applied is 
that of predicting acute dysphagia in non-small cell lung 
cancer (NSCLC) patients. 
Acute dysphagia occurs frequently during concurrent chemo-
radiation or high-dose radiotherapy for lung cancer. It is a 
dose limiting toxicity that can lead to treatment 
interruptions and thereby reduce chances of survival. 
Previously, we have developed models to predict this 
toxicity. However, the performance of these models is not 
perfect. This may be because these models were based on 
data from historical patients (e.g. 3D-CRT) which do not 
reflect current practice (e.g. IMRT and VMAT). In this study, 
we investigated whether a model, that attributes more 
weight to recent patient data in its training set, predicts 
dysphagia with a higher accuracy than a model that treats old 
and new data as equally important. 
Rectal Bleeding (RB)  Analytical Data-driven 
Radiogenomic 0.547 0.794 
Dosimetric 0.522 0.747 
Erectile Dysfunction (ED) Analytical Data-driven 
Radiogenomic 0.618 0.707 
Dosimetric 0.562 0.577 
